# Eagle Bancorp Montana, Inc.: overview EBMT · Nasdaq · CIK 1478454 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ebmt.md) · [Financials](/companies/ebmt/financials.md) · [Filings](/companies/ebmt/filings.md) · [Insiders](/companies/ebmt/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.34](/filings/0001437749-25-033182.md) | not reported | [0.41](/filings/0001437749-26-015453.md) | [0.41](/filings/0001437749-26-025842.md) | [0.46](/filings/0001437749-25-033182.md) | not reported | [0.51](/filings/0001437749-26-015453.md) | [0.47](/filings/0001437749-26-025842.md) | | Free cash flow | $m | [(0.7) d](/filings/0001437749-25-033182.md) | [12.2 d](/filings/0001437749-26-007330.md) | [0.3](/filings/0001437749-26-015453.md) | [1.4 d](/filings/0001437749-26-025842.md) | [7.1 d](/filings/0001437749-25-033182.md) | [19.6 d](/filings/0001437749-26-007330.md) | [(5.2)](/filings/0001437749-26-015453.md) | [(2.8) d](/filings/0001437749-26-025842.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.17](/filings/0001437749-23-005778.md) | [1.45](/filings/0001437749-24-006812.md) | [1.29](/filings/0001437749-25-007739.md) | [1.24](/filings/0001437749-26-007330.md) | [1.90](/filings/0001437749-26-007330.md) | | Free cash flow | $m | [44.2](/filings/0001437749-23-005778.md) | [25.1](/filings/0001437749-24-006812.md) | [(4.8)](/filings/0001437749-25-007739.md) | [14.5](/filings/0001437749-26-007330.md) | [28.3](/filings/0001437749-26-007330.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ebmt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $15.6m | 652,376 | | Added +154,769 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $9.5m | 395,656 | | Reduced −2,707 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $7.8m | 327,051 | | Reduced −22,664 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $6.6m | 277,683 | | Added +55,385 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.5m | 187,708 | | Added +15,225 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $3.7m | 155,322 | | Added +70,604 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.1m | 131,331 | | Added +62,321 | | [O'SHAUGHNESSY ASSET MANAGEMENT, LLC](/funds/1423442.md) | 2026-06-30 | $2.7m | 112,667 | | Added +11,651 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.6m | 108,567 | | Added +17,019 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $2.5m | 102,581 | | Added +12,732 | ## Recent filings [All 791 filings](/companies/ebmt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 16:00 ET | [8-K](/filings/0001171843-26-006855.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006855 | | 2026-10-01 | 16:51 ET | [8-K](/filings/0001437749-26-031748.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-031748 | | 2026-08-05 | 12:08 ET | [10-Q](/filings/0001437749-26-025842.md) | Quarterly report, period 2026-06-30 | 0001437749-26-025842 | | 2026-07-28 | 16:00 ET | [8-K](/filings/0001171843-26-004940.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004940 | | 2026-07-17 | 16:48 ET | [8-K](/filings/0001437749-26-023769.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-023769 | | 2026-05-18 | 16:01 ET | [8-K](/filings/0001171843-26-003509.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003509 | | 2026-05-07 | 12:22 ET | [10-Q](/filings/0001437749-26-015453.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015453 | | 2026-05-04 | 10:00 ET | [8-K](/filings/0001171843-26-002964.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002964 | | 2026-04-29 | 16:10 ET | [8-K](/filings/0001437749-26-013873.md) | 5.07 Shareholder vote results | 0001437749-26-013873 | | 2026-04-28 | 16:00 ET | [8-K](/filings/0001171843-26-002773.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002773 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-007330.md), filed Mar 9, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1478454 - Tickers: EBMT - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:01 ET. No prices; not investment advice.